Jie-wei Luo
Impact in
-
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Function and Risk Factors
Papers in
-
- Gut microbiota and health 3
- RNA Research and Splicing 3
- Co-authors
- Jianbin Huang (4 shared papers)Dan‐dan Ruan (32 shared papers)Jingjing Li (1 shared paper)Jin Zhao (1 shared paper)Zhu-ting Fang (24 shared papers)Hanlu Wang (10 shared papers)Jianhui Zhang (19 shared papers)Qiuyan Wu (9 shared papers)
- Journals
- Abdominal Radiology (4 papers)Frontiers in Cardiovascular Medicine (4 papers)Neurological Sciences (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Heliyon (2 papers)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Jie-wei Luo
61 papers receiving 330 citations
Peers
Comparison fields: 5 of 75
- Complementary and alternative medicine 17
- Cardiology and Cardiovascular Medicine 43
- Nephrology 14
- Cancer Research 25
- Urology 9
Countries citing papers authored by Jie-wei Luo
This map shows the geographic impact of Jie-wei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie-wei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie-wei Luo more than expected).
Fields of papers citing papers by Jie-wei Luo
This network shows the impact of papers produced by Jie-wei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie-wei Luo. The network helps show where Jie-wei Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jie-wei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 62 | |
| 2 | 2023 | 20 | |
| 3 | Differences in gut microbiota structure in patients with stages 4-5 chronic kidney disease. | 2021 | 17 |
| 4 | 2019 | 14 | |
| 5 | 2023 | 11 | |
| 6 | 2018 | 11 | |
| 7 | 2025 | 10 | |
| 8 | 2016 | 9 | |
| 9 | 2018 | 9 | |
| 10 | 2023 | 8 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2020 | 7 | |
| 14 | Oxymatrine inhibits the development of non-small cell lung cancer through miR-367-3p upregulation and target gene SGK3 downregulation. | 2020 | 7 |
| 15 | 2022 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2021 | 5 | |
| 19 | 2020 | 5 | |
| 20 | Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment. | 2022 | 5 |
About Jie-wei Luo
Jie-wei Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Physiology and Surgery, having authored 71 papers that have together received 332 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (5 papers), Nanoplatforms for cancer theranostics (4 papers), Gut microbiota and health (3 papers), RNA Research and Splicing (3 papers), Parathyroid Disorders and Treatments (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Lysosomal Storage Disorders Research (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). The work is most often cited by research in Complementary and alternative medicine (17 citations), Cardiology and Cardiovascular Medicine (43 citations), Nephrology (14 citations), Cancer Research (25 citations) and Urology (9 citations). Jie-wei Luo has collaborated with scholars based in China and South Korea. Frequent co-authors include Jianbin Huang, Dan‐dan Ruan, Jingjing Li, Jin Zhao, Zhu-ting Fang, Hanlu Wang, Jianhui Zhang, Qiuyan Wu, Shijie Li and Qiuping Ma. Their work appears in journals such as Abdominal Radiology, Frontiers in Cardiovascular Medicine, Neurological Sciences, Evidence-based Complementary and Alternative Medicine and Heliyon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.